Compare CYTK & IAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | IAG |
|---|---|---|
| Founded | 1997 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.8B |
| IPO Year | 2004 | 2002 |
| Metric | CYTK | IAG |
|---|---|---|
| Price | $56.27 | $17.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 14 |
| Target Price | ★ $109.42 | $22.79 |
| AVG Volume (30 Days) | 1.9M | ★ 5.0M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,368,000.00 | N/A |
| Revenue This Year | $87.17 | $30.17 |
| Revenue Next Year | $170.90 | $8.51 |
| P/E Ratio | ★ N/A | $18.66 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $53.58 | $12.63 |
| 52 Week High | $88.31 | $24.87 |
| Indicator | CYTK | IAG |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 47.64 |
| Support Level | N/A | $16.17 |
| Resistance Level | $66.62 | $18.89 |
| Average True Range (ATR) | 2.69 | 0.78 |
| MACD | -0.24 | 0.15 |
| Stochastic Oscillator | 24.29 | 46.10 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.